Oscar Health is trading 4.03% lower at $29.30, apparently amid broader financial-sector weakness; no company-specific announcement was identified for September 24, 2026. - XLF fell 2.04% in regular trading amid concerns over higher Treasury yields and AI disruption pressuring financial companies. - U.S. stocks were lower as the 10-year Treasury yield reached 5.14%; resilient economic data and Brent crude above $100 reinforced expectations for elevated interest rates. - Oscar Health’s recent analyst consensus remains Hold.